Translating local innovation into statewide policy: Lessons from a medications for addiction treatment (MAT) prior authorization pilot in Camden, New Jersey

Author
Natasha Dravid and Alex Staropoli
Date
August 19, 2019
January 9, 2020
On the Health Affairs blog: RCT results show a way forward for the Camden Coalition and complex care
In this blog post published on the Health Affairs blog, CEO Kathleen Noonan discusses lessons from the Camden Coalition RCT.
Kathleen Noonan
January 8, 2020
The Camden Core Model RCT shows us a path forward for complex care
A message from our CEO Kathleen Noonan on next steps after the evaluation of our care management intervention, published today in NEJM
Kathleen Noonan
Camden Coalition staff review a whiteboard with patient enrollment information
January 8, 2020
Sharing evidence to inform the future of healthcare delivery and complex care: Lessons from the Camden Coalition and J-PAL North America partnership
Part 2 of a Q&A blog series describing the partnership between the Camden Coalition and researchers affiliated with J-PAL North America.
Kathleen Noonan, Aaron Truchil, Amy Finkelstein
Camden Coalition staff hold whiteboard showing RCT enrollment numbers
January 8, 2020
Evaluating the Camden Core Model: How a research partnership between the Camden Coalition and J-PAL North America was built
Part 1 of a Q&A blog series describing the partnership between the Camden Coalition and researchers affiliated with J-PAL North America.
Kathleen Noonan, Aaron Truchil, Amy Finkelstein
November 14, 2019
It takes an ecosystem: Finding success in complex care
Read the Putting Care at the Center 2019 opening remarks by Kathleen Noonan, CEO
Kathleen Noonan
Putting Care at the Center attendees converse at a table.
October 29, 2019
Camden Coalition partners with the Better Care Playbook to share practical solutions for serving complex populations
Lessons from our local and national innovations that offer guidance for serving complex populations.
Mavis Asiedu-Frimpong

Between 2016 and 2017, New Jersey had the second highest increase in overdose deaths in the country. Improving access to medications for addiction treatment (MAT) is a critical tool in preventing these avoidable deaths. Having identified prior authorization as a barrier to accessing buprenorphine — one form of MAT — the Camden Coalition worked with local stakeholders to implement a pilot program that eliminated prior authorization for this life-saving medication in certain circumstances. The successful results of the pilot, along with collective advocacy at the state level, led to the removal of this administrative barrier for Medicaid beneficiaries across the state of New Jersey earlier this year. 

This Camden Coalition brief outlines the nuts and bolts of the pilot program and our work alongside partners at the local and state levels to translate the pilot into successful statewide policy.

Read the brief

Stay Informed

Join our mailing list to get the latest updates sent right to your inbox from the Camden Coalition.

Sign Up